Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study

Minjeong Jeon, Yubin Lee, Jieun Woo, Ju Hwan Kim, Ju-Young Shin

Open source

DOI
10.1038/s41408-026-01557-0
Published
2026-07-01
Container
Blood Cancer Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41408-026-01557-0,
  title = {Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study},
  author = {Minjeong Jeon and Yubin Lee and Jieun Woo and Ju Hwan Kim and Ju-Young Shin},
  year = {2026},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-026-01557-0},
  url = {https://doi.org/10.1038/s41408-026-01557-0}
}

RIS

TY  - JOUR
TI  - Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study
AU  - Minjeong Jeon
AU  - Yubin Lee
AU  - Jieun Woo
AU  - Ju Hwan Kim
AU  - Ju-Young Shin
PY  - 2026
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-026-01557-0
UR  - https://doi.org/10.1038/s41408-026-01557-0
ER  - 

APA

Jeon, M., Lee, Y., Woo, J., Kim, J. H., & Shin, J. (2026). Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01557-0

Source records